Constellium
CSTM
Constellium (CSTM) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Initiated Coverage | Equal-Weight | $28.00 | Oct 14, 2026 |
| Deutsche Bank | Maintained | Buy | $36.00 from $39.00 | Oct 8, 2026 |
| UBS | Maintained | Buy | $32.00 from $34.00 | Oct 8, 2026 |
| Wells Fargo | Maintained | Overweight | $38.00 from $39.00 | Sep 18, 2026 |
| Wells Fargo | Maintained | Overweight | $39.00 from $37.00 | Jul 30, 2026 |
| Wells Fargo | Maintained | Overweight | $37.00 from $39.00 | Jul 9, 2026 |
| UBS | Maintained | Buy | $35.00 from $38.00 | Jul 8, 2026 |
| UBS | Initiated Coverage | Buy | $38.00 | May 5, 2026 |
| Wells Fargo | Maintained | Overweight | $39.00 from $35.00 | Apr 30, 2026 |
| JP Morgan | Downgraded | Overweight → Neutral | $34.00 from $30.00 | Apr 30, 2026 |
| Wells Fargo | Maintained | Overweight | $35.00 from $29.00 | Apr 16, 2026 |
| JP Morgan | Maintained | Overweight | $30.00 from $29.00 | Apr 16, 2026 |
| BMO Capital | Maintained | Outperform | $30.00 from $25.00 | Feb 19, 2026 |
| Deutsche Bank | Maintained | Buy | $28.00 from $25.00 | Feb 19, 2026 |
| Wells Fargo | Maintained | Overweight | $29.00 from $25.00 | Feb 19, 2026 |
| JP Morgan | Maintained | Overweight | $29.00 from $26.00 | Feb 19, 2026 |
| Wells Fargo | Upgraded | Equal-Weight → Overweight | $25.00 from $17.00 | Jan 13, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $17.00 from $16.00 | Oct 30, 2025 |
| JP Morgan | Maintained | Overweight | $22.00 from $17.00 | Oct 30, 2025 |
| Wells Fargo | Initiated Coverage | Equal-Weight | $16.00 | Oct 8, 2025 |
Frequently asked questions
What is the latest analyst rating on CSTM?
On Oct 14, 2026, Barclays initiated coverage of Constellium at Equal-Weight with a price target of $28.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.